Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Austria

 

Will record results for Synlab precipitate Cinven sale?

Almost a year after its IPO, lab giant Synlab has posted strong FY21 results bolstered by Covid, but not, it says, dependant on it. Management say extra cash will be used as a springboard for growth. Could it also lead to private equity majority shareholder Cinven selling its remaining interest?

HBI 2021: Data drives efficiencies in healthcare systems

AI is not the be-all and end-all of efficiency in healthcare, a more basic automation and understanding of data can drive 10%+ savings. However, payors must be prepared to share some of this with their partners.

Consortium buys German lab group amedes

German lab group amedes is selling to a consortium including Canada's OMERS Infrastructure, Goldman Sachs Asset Management, and asset manager AXA Investment Managers.

Sovereign wealth funds big Asia-Pacific plays

Sovereign wealth funds are making some big entrances and exits in the Asia-Pacific with bids closing in QIC-owned oncology player Icon Group and Singapore's GIC acquiring a minority stake in Sunway hospital group Sunway Healthcare.

Social care job applications drop as economies open

Job applications for social care have dropped off a cliff in the UK as the economy starts to open up, according to an operator. Groups in Germany, France, the Netherlands and Austria say they are still seeing a surge.

Ameos sale/refinancing: Speculation mounts as group denies discussions

Despite emphatic denials from the company itself that it is for sale, multiple sources continue to tell HBI that DACH psychiatry and acute hospital group Ameos is in discussion with potential suitors and that documentation preparing for refinancing and/or sale has been drawn up. HBI speaks to an operator source, a consultant, and the company to find out more.

Ameos “prepares for sale or refinancing”

Multiple sources tell HBI that DACH psychiatry and acute hospital group Ameos is preparing for sale or refinancing. The group vehemently denies it is preparing for sale.

Find Us